### 26281 Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices

Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@AHRQ.hhs.

gov.

**SUPPLEMENTARY INFORMATION :** 
Background

The Patient Safety Act, Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety Rule, 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. Accordingly, CareRise LLC, PSO number P0058, was delisted effective at 12:00 Midnight ET (2400) on March 30, 2012.

More information on PSOs can be obtained through AHRQ’s PSO Web site

at http://www.pso.AHRQ.gov/index.
html.

Dated: April 24, 2012. Carolyn M. Clancy,

Director.

[FR Doc. 2012–10596 Filed 5–2–12; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**National Advisory Council for Healthcare Research and Quality:**  **Request for Nominations for Public**

**Members**

**AGENCY :**  Agency for Healthcare Research and Quality (AHRQ), HHS.

**ACTION :**  Notice of request for nominations for public members.

**SUMMARY :**  42 U.S.C. 299c establishes a National Advisory Council for Healthcare Research and Quality (the Council). The Council is to advise the Secretary of HHS (Secretary) and the Director of the Agency for Healthcare Research and Quality (AHRQ) on matters related to activities of the Agency to improve the quality, safety, efficiency, and effectiveness of health
care for all Americans.

Seven current members’ terms will expire in November 2012. To fill these positions, we are seeking individuals who are distinguished: (1) In the conduct of research, demonstration projects, and evaluations with respect to health care; (2) in the fields of health care quality research or health care improvement; (3) in the practice of medicine; (4) in other health professions; (5) in representing the private health care sector (including health plans, providers, and purchasers) or administrators of health care delivery systems; (6) in the fields of health care economics, information systems, law, ethics, business, or public policy; and, (7) in representing the interests of patients and consumers of health care. 42 U.S.C. 299c(c)(2). Individuals are particularly sought with experience and success in activities specified in the summary above.

**DATES :**  Nominations should be received on or before 60 days after date of publication.

**ADDRESSES :**  Nominations should be sent to Ms. Karen Brooks, AHRQ, 540 Gaither Road, Room 3006, Rockville, Maryland 20850. Nominations may also
be emailed to Karen.Brooks@ahrq.hhs.gov.

**FOR FURTHER INFORMATION CONTACT :**  Ms. Karen Brooks, AHRQ, at (301) 427–

1801.

**SUPPLEMENTARY INFORMATION :**  42 U.S.C. 299c provides that the Secretary shall appoint to the National Advisory
Council for Healthcare Research and Quality twenty one appropriately qualified individuals. At least seventeen members shall be representatives of the public and at least one member shall be a specialist in the rural aspects of one or more of the professions or fields listed in the above summary. In addition, the Secretary designates, as ex officio members, representatives from other Federal agencies, principally agencies that conduct or support health care research, as well as Federal officials the Secretary may consider appropriate. 42 U.S.C. 299c(c)(3). The Council meets in the Washington, DC, metropolitan area, generally in Rockville, Maryland, approximately three times a year to provide broad guidance to the Secretary and AHRQ’s Director on the direction of and programs undertaken by AHRQ.

Seven individuals will be selected presently by the Secretary to serve on the Council beginning with the meeting in the spring of 2012. Members generally serve 3-year terms. Appointments are staggered to permit an orderly rotation of membership.

Interested persons may nominate one or more qualified persons formembership on the Council. Selfnominations are accepted. Nominations shall include: (1) A copy of the nominee’s resume or curriculum vitae; and (2) a statement that the nominee is willing to serve as a member of the
Council. Selected candidates will be asked to provide detailed information concerning their financial interests, consultant positions and research grants and contracts, to permit evaluation of possible sources of conflict of interest. Please note that once you are nominated, AHRQ may consider your nomination for future positions on the Council. Federally registered lobbyists are not permitted to serve on this advisory board pursuant to the
Presidential Memorandum entitled ‘‘Lobbyists on Agency Boards and Commissions’’ dated June 10, 2010, and the Office of Management and Budget’s ‘‘Final Guidance on Appointment of Lobbyists to Federal Boards and Commissions,’’ 76 FR 61756 (October 5, 2011).

The Department seeks a broad geographic representation. In addition, AHRQ conducts and supports research concerning priority populations, which include: Low-income groups; minority groups; women; children; the elderly; and individuals with special health care needs, including individuals with
disabilities and individuals who need
chronic care or end-of-life health care. See 42 U.S.C. 299(c). Nominations of persons with expertise in health care for these priority populations are encouraged.

Dated: April 24, 2012. Carolyn M. Clancy,

Director.

[FR Doc. 2012–10595 Filed 5–2–12; 8:45 am]

**BILLING CODE 4160–90–M**

**DEPARTMENT OF HEALTH AND**
**HUMAN SERVICES**

**Food and Drug Administration**

**[Docket No.FDA–2012–N–0386]**

**Agency Information Collection Activities; Proposed Collection;**  **Comment Request; Registration and Product Listing for Owners and**  **Operators of Domestic Tobacco Product Establishments and Listing of**  **Ingredients in Tobacco Products**

**AGENCY :**  Food and Drug Administration,

HHS.